Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review

Lade, Harshad, Kim, Jae-Seok·2023·Antibiotics

Abstract

The development of antibiotic resistance in Staphylococcus aureus, particularly in methicillin-resistant S. aureus (MRSA), has become a significant health concern worldwide. The acquired mecA gene encodes penicillin-binding protein 2a (PBP2a), which takes over the activities of endogenous PBPs and, due to its low affinity for β-lactam antibiotics, is the main determinant of MRSA. In addition to PBP2a, other genetic factors that regulate cell wall synthesis, cell signaling pathways, and metabolism are required to develop high-level β-lactam resistance in MRSA. Although several genetic factors that modulate β-lactam resistance have been identified, it remains unclear how they alter PBP2a expression and affect antibiotic resistance. This review describes the molecular determinants of β-lactam resistance in MRSA, with a focus on recent developments in our understanding of the role of mecA-encoded PBP2a and on other genetic factors that modulate the level of β-lactam resistance. Understanding the molecular determinants of β-lactam resistance can aid in developing novel strategies to combat MRSA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics12091362

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 156

  1. Lowy, 1998, Staphylococcus aureus Infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
  2. Fleming, 1929, On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae, Br. J. Exp. Pathol., 10, 226
  3. Abraham, D.J. (2021). Burger’s Medicinal Chemistry, Drug Discovery and Development, Wiley.
  4. Brown, 2021, Treatment of methicillin-resistant Staphylococcus aureus (MRSA): Updated guidelines from the UK, JAC-Antimicrob. Resist., 3, dlaa114, 10.1093/jacamr/dlaa114 · DOI · Paper page
  5. Liu, 2011, Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children, Clin. Infect. Dis., 52, e18, 10.1093/cid/ciq146 · DOI · Paper page
  6. Rammelkamp, 1942, Resistance of Staphylococcus aureus to the Action of Penicillin, Exp. Biol. Med., 51, 386, 10.3181/00379727-51-13986 · DOI · Paper page
  7. Kirby, 1944, Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci, Science, 99, 452, 10.1126/science.99.2579.452 · DOI · Paper page
  8. Abraham, 1940, An enzyme from bacteria able to destroy penicillin, Nature, 146, 837, 10.1038/146837a0 · DOI · Paper page
  9. Knox, 1960, A New Penicillin (BRL 1241) Active Against Penicillin-resistant Staphylococci, BMJ, 2, 690, 10.1136/bmj.2.5200.690 · doi:10.1136/bmj.2.5200.690
  10. Jevons, 1961, “Celbenin”—resistant Staphylococci, Br. Med. J., 1, 124, 10.1136/bmj.1.5219.124-a · DOI · Paper page
  11. Harkins, 2017, Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice, Genome Biol., 18, 130, 10.1186/s13059-017-1252-9 · DOI · Paper page
  12. Hartman, 1984, Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus, J. Bacteriol., 158, 513, 10.1128/jb.158.2.513-516.1984 · DOI · Paper page
  13. Utsui, 1985, Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 28, 397, 10.1128/AAC.28.3.397 · DOI · Paper page
  14. Matsuhashi, 1986, Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus, J. Bacteriol., 167, 975, 10.1128/jb.167.3.975-980.1986 · DOI · Paper page
  15. Turner, 2019, Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research, Nat. Rev. Microbiol., 17, 203, 10.1038/s41579-018-0147-4 · DOI · Paper page
  16. Arias, 2009, Antibiotic-Resistant Bugs in the 21st Century—A Clinical Super-Challenge, N. Engl. J. Med., 360, 439, 10.1056/NEJMp0804651 · DOI · Paper page
  17. Lakhundi, 2018, Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology, Clin. Microbiol. Rev., 31, e00020-18, 10.1128/CMR.00020-18 · DOI · Paper page
  18. Panlilio, 1992, Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991, Infect. Control Hosp. Epidemiol., 13, 582, 10.1086/646432 · DOI · Paper page
  19. Klein, 2007, Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005, Emerg. Infect. Dis., 13, 1840, 10.3201/eid1312.070629 · DOI · Paper page
  20. Murray, 2022, Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis, Lancet, 399, 629, 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
  21. Kim, C., Mwangi, M., Chung, M., Milheirço, C., de Lencastre, H., and Tomasz, A. (2013). The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response. PLoS ONE, 8. · DOI
  22. Peacock, 2015, Mechanisms of Methicillin Resistance in Staphylococcus aureus, Annu. Rev. Biochem., 84, 577, 10.1146/annurev-biochem-060614-034516 · DOI · Paper page
  23. Ryffel, 1994, Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 38, 724, 10.1128/AAC.38.4.724 · DOI
  24. Finan, 2002, Conversion of Oxacillin-Resistant Staphylococci from Heterotypic to Homotypic Resistance Expression, Antimicrob. Agents Chemother., 46, 24, 10.1128/AAC.46.1.24-30.2002 · DOI
  25. Gallagher, 2017, Tandem Amplification of the Staphylococcal Cassette Chromosome mec Element Can Drive High-Level Methicillin Resistance in Methicillin-Resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 61, e0086917, 10.1128/AAC.00869-17 · DOI
  26. Katayama, 2000, A New Class of Genetic Element, Staphylococcus Cassette Chromosome mec, Encodes Methicillin Resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 44, 1549, 10.1128/AAC.44.6.1549-1555.2000 · DOI · Paper page
  27. Hiramatsu, 1992, Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA), FEBS Lett., 298, 133, 10.1016/0014-5793(92)80039-J · DOI · Paper page
  28. Boundy, 2013, Characterization of the Staphylococcus aureus rRNA Methyltransferase Encoded by orfX, the Gene Containing the Staphylococcal Chromosome Cassette mec (SCCmec) Insertion Site, J. Biol. Chem., 288, 132, 10.1074/jbc.M112.385138 · DOI
  29. Ito, 1999, Cloning and Nucleotide Sequence Determination of the Entire mec DNA of Pre-Methicillin-Resistant Staphylococcus aureus N315, Antimicrob. Agents Chemother., 43, 1449, 10.1128/AAC.43.6.1449 · DOI · Paper page
  30. Holden, 2011, Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: A descriptive study, Lancet Infect. Dis., 11, 595, 10.1016/S1473-3099(11)70126-8 · DOI · Paper page
  31. Ballhausen, 2014, The mecA Homolog mecC Confers Resistance against β-Lactams in Staphylococcus aureus Irrespective of the Genetic Strain Background, Antimicrob. Agents Chemother., 58, 3791, 10.1128/AAC.02731-13 · DOI
  32. Tsubakishita, 2010, Origin and Molecular Evolution of the Determinant of Methicillin Resistance in Staphylococci, Antimicrob. Agents Chemother., 54, 4352, 10.1128/AAC.00356-10 · DOI · Paper page
  33. Zhou, 2008, Penicillin-Binding Proteins and Cell Wall Composition in β-Lactam-Sensitive and -Resistant Strains of Staphylococcus sciuri, J. Bacteriol., 190, 508, 10.1128/JB.01549-07 · doi:10.1128/jb.01549-07
  34. Couto, 1996, Ubiquitous Presence of a mecA Homologue in Natural Isolates of Staphylococcus sciuri, Microb. Drug Resist., 2, 377, 10.1089/mdr.1996.2.377 · DOI · Paper page
  35. Hanssen, 2006, SCC mec in staphylococci: Genes on the move, FEMS Immunol. Med. Microbiol., 46, 8, 10.1111/j.1574-695X.2005.00009.x · DOI · Paper page
  36. Hiramatsu, 1995, Molecular Evolution of MRSA, Microbiol. Immunol., 39, 531, 10.1111/j.1348-0421.1995.tb02239.x · DOI · Paper page
  37. Ito, 2009, Classification of staphylococcal cassette chromosome mec (SCCmec): Guidelines for reporting novel SCCmec elements, Antimicrob. Agents Chemother., 53, 4961, 10.1128/AAC.00579-09 · DOI · Paper page
  38. Uehara, Y. (2022). Current Status of Staphylococcal Cassette Chromosome mec (SCCmec). Antibiotics, 11. · DOI
  39. Lee, 2018, Methicillin-resistant Staphylococcus aureus, Nat. Rev. Dis. Prim., 4, 18033, 10.1038/nrdp.2018.33 · DOI · Paper page
  40. Ito, 2001, Structural Comparison of Three Types of Staphylococcal Cassette Chromosome mec Integrated in the Chromosome in Methicillin-Resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 45, 1323, 10.1128/AAC.45.5.1323-1336.2001 · DOI · Paper page
  41. Wielders, 2001, Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus, Lancet, 357, 1674, 10.1016/S0140-6736(00)04832-7 · DOI · Paper page
  42. Bloemendaal, A.L.A., Brouwer, E.C., and Fluit, A.C. (2010). Methicillin Resistance Transfer from Staphylocccus epidermidis to Methicillin-Susceptible Staphylococcus aureus in a Patient during Antibiotic Therapy. PLoS ONE, 5. · DOI
  43. Becker, 2018, Plasmid-Encoded Transferable mecB -Mediated Methicillin Resistance in Staphylococcus aureus, Emerg. Infect. Dis., 24, 242, 10.3201/eid2402.171074 · DOI · Paper page
  44. Nielsen, 1982, Membrane-bound penicillinases in Gram-positive bacteria, J. Biol. Chem., 257, 4490, 10.1016/S0021-9258(18)34749-5 · DOI
  45. Fisher, 2021, β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium, Chem. Rev., 121, 3412, 10.1021/acs.chemrev.0c01010 · DOI
  46. Holden, 2004, Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the evolution of virulence and drug resistance, Proc. Natl. Acad. Sci. USA, 101, 9786, 10.1073/pnas.0402521101 · DOI · Paper page
  47. Wright, G.D. (2010). Q&A: Antibiotic resistance: Where does it come from and what can we do about it?. BMC Biol., 8. · DOI · Paper page
  48. Hackbarth, 1993, blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 37, 1144, 10.1128/AAC.37.5.1144 · DOI · Paper page
  49. Zhang, 2001, A Proteolytic Transmembrane Signaling Pathway and Resistance to β-Lactams in Staphylococci, Science, 291, 1962, 10.1126/science.1055144 · DOI · Paper page
  50. Gregory, 1997, Studies of the repressor (BlaI) of β-lactamase synthesis in Staphylococcus aureus, Mol. Microbiol., 24, 1025, 10.1046/j.1365-2958.1997.4051770.x · DOI
  51. Llarrull, 2014, Regulation of the expression of the β-lactam antibiotic-resistance determinants in methicillin-resistant Staphylococcus aureus (MRSA), Biochemistry, 53, 1548, 10.1021/bi500074w · DOI
  52. Herzberg, 1987, Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å Resolution, Science, 236, 694, 10.1126/science.3107125 · DOI · Paper page
  53. Alexander, 2023, Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus, Nature, 613, 375, 10.1038/s41586-022-05583-3 · DOI
  54. Richmond, 1965, Wild-type variants of exopenicillinase from Staphylococcus aureus, Biochem. J., 94, 584, 10.1042/bj0940584 · doi:10.1042/bj0940584
  55. Zygmunt, 1992, Characterization of four beta-lactamases produced by Staphylococcus aureus, Antimicrob. Agents Chemother., 36, 440, 10.1128/AAC.36.2.440 · DOI
  56. Kernodle, 1989, Differentiation of -Lactamase Variants of Staphylococcus aureus by Substrate Hydrolysis Profiles, J. Infect. Dis., 159, 103, 10.1093/infdis/159.1.103 · DOI
  57. Kernodle, 1990, Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants, Antimicrob. Agents Chemother., 34, 420, 10.1128/AAC.34.3.420 · DOI
  58. Typas, 2012, From the regulation of peptidoglycan synthesis to bacterial growth and morphology, Nat. Rev. Microbiol., 10, 123, 10.1038/nrmicro2677 · DOI · Paper page
  59. Burns, 2020, The architecture of the Gram-positive bacterial cell wall, Nature, 582, 294, 10.1038/s41586-020-2236-6 · DOI · Paper page
  60. Schneider, 2010, An oldie but a goodie—cell wall biosynthesis as antibiotic target pathway, Int. J. Med. Microbiol., 300, 161, 10.1016/j.ijmm.2009.10.005 · DOI · Paper page
  61. Pinho, 2013, How to get (a)round: Mechanisms controlling growth and division of coccoid bacteria, Nat. Rev. Microbiol., 11, 601, 10.1038/nrmicro3088 · DOI · Paper page
  62. Pereira, 2007, Role of PBP1 in Cell Division of Staphylococcus aureus, J. Bacteriol., 189, 3525, 10.1128/JB.00044-07 · DOI
  63. Atilano, 2010, Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus, Proc. Natl. Acad. Sci. USA, 107, 18991, 10.1073/pnas.1004304107 · DOI · Paper page
  64. Pinho, 2003, Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery, Mol. Microbiol., 50, 871, 10.1046/j.1365-2958.2003.03719.x · DOI · Paper page
  65. Lovering, 2007, Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis, Science, 315, 1402, 10.1126/science.1136611 · DOI · Paper page
  66. Reed, 2011, Monofunctional Transglycosylases Are Not Essential for Staphylococcus aureus Cell Wall Synthesis, J. Bacteriol., 193, 2549, 10.1128/JB.01474-10 · DOI
  67. Wacnik, 2022, Penicillin-Binding Protein 1 (PBP1) of Staphylococcus aureus Has Multiple Essential Functions in Cell Division, MBio, 13, e0066922, 10.1128/mbio.00669-22 · DOI
  68. Tomasz, 2005, Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: Evidence for the cooperative functioning of PBP2, PBP4, and PBP2A, J. Bacteriol., 187, 1815, 10.1128/JB.187.5.1815-1824.2005 · DOI · Paper page
  69. Pinho, 2004, Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates, Mol. Microbiol., 55, 799, 10.1111/j.1365-2958.2004.04420.x · DOI · Paper page
  70. Pinho, 2001, Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureus, J. Bacteriol., 183, 6525, 10.1128/JB.183.22.6525-6531.2001 · DOI · Paper page
  71. Barbuti, 2023, The cell cycle of Staphylococcus aureus: An updated review, Microbiologyopen, 12, e1338, 10.1002/mbo3.1338 · DOI
  72. Reichmann, 2019, SEDS–bPBP pairs direct lateral and septal peptidoglycan synthesis in Staphylococcus aureus, Nat. Microbiol., 4, 1368, 10.1038/s41564-019-0437-2 · DOI
  73. Loskill, 2014, Reduction of the Peptidoglycan Crosslinking Causes a Decrease in Stiffness of the Staphylococcus aureus Cell Envelope, Biophys. J., 107, 1082, 10.1016/j.bpj.2014.07.029 · DOI
  74. Pinho, 2000, Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus, J. Bacteriol., 182, 1074, 10.1128/JB.182.4.1074-1079.2000 · DOI
  75. Pinho, 2001, An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci, Proc. Natl. Acad. Sci. USA, 98, 10886, 10.1073/pnas.191260798 · DOI · Paper page
  76. Bilyk, 2022, An Interplay of Multiple Positive and Negative Factors Governs Methicillin Resistance in Staphylococcus aureus, Microbiol. Mol. Biol. Rev., 86, e0015921, 10.1128/mmbr.00159-21 · DOI
  77. Foster, 2017, Antibiotic resistance in Staphylococcus aureus. Current status and future prospects, FEMS Microbiol. Rev., 41, 430, 10.1093/femsre/fux007 · DOI · Paper page
  78. Llarrull, 2009, Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New β-Lactams That Meet the Challenge, Antimicrob. Agents Chemother., 53, 4051, 10.1128/AAC.00084-09 · DOI
  79. Pucci, 2002, Direct Quantitation of the Numbers of Individual Penicillin-Binding Proteins per Cell in Staphylococcus aureus, J. Bacteriol., 184, 588, 10.1128/JB.184.2.588-591.2002 · DOI
  80. Jones, 2010, Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: Results from an international surveillance study, J. Antimicrob. Chemother., 65, iv17, 10.1093/jac/dkq252 · DOI
  81. Kelley, 2015, Missense mutations in PBP2A affecting ceftaroline susceptibility detected in epidemic hospital-acquired Methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998, Antimicrob. Agents Chemother., 59, 1922, 10.1128/AAC.04068-14 · DOI
  82. McNeil, 2022, Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: A Clinical and Genomic Investigation, Antimicrob. Agents Chemother., 66, e0074522, 10.1128/aac.00745-22 · doi:10.1128/aac.00745-22
  83. Long, 2014, PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates, Antimicrob. Agents Chemother., 58, 6668, 10.1128/AAC.03622-14 · DOI
  84. Lahiri, 2015, Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: The role of PBP2a in the activity of ceftaroline, J. Antimicrob. Chemother., 70, 2488, 10.1093/jac/dkv131 · DOI
  85. Lee, 2018, Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 62, e00485-18, 10.1128/AAC.00485-18 · DOI · Paper page
  86. Chan, 2015, Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 59, 2960, 10.1128/AAC.05004-14 · doi:10.1128/aac.05004-14
  87. Wallick, 1974, Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Susceptibility Studies, Antimicrob. Agents Chemother., 5, 25, 10.1128/AAC.5.1.25 · doi:10.1128/aac.5.1.25
  88. Kariyone, 1970, Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin, J. Antibiot., 23, 131, 10.7164/antibiotics.23.131 · DOI
  89. Nishida, 1970, Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity, J. Antibiot., 23, 137, 10.7164/antibiotics.23.137 · doi:10.7164/antibiotics.23.137
  90. Yotsuji, 1988, Mechanism of action of cephalosporins and resistance caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis, Antimicrob. Agents Chemother., 32, 1848, 10.1128/AAC.32.12.1848 · DOI
  91. Ishikawa, 2003, TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: Synthesis, physicochemical and pharmacological properties, Bioorg. Med. Chem., 11, 2427, 10.1016/S0968-0896(03)00126-3 · DOI
  92. Alexander, 2018, Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in Staphylococcus aureus, J. Biol. Chem., 293, 19854, 10.1074/jbc.RA118.004952 · DOI
  93. Hamilton, 2017, High-level resistance of Staphylococcus aureus to β-Lactam antibiotics mediated by penicillin-binding protein 4 (PBP4), Antimicrob. Agents Chemother., 61, e02727-16, 10.1128/AAC.02727-16 · DOI
  94. Greninger, A.L., Chatterjee, S.S., Chan, L.C., Hamilton, S.M., Chambers, H.F., and Chiu, C.Y. (2016). Whole-genome sequencing of methicillin-resistant Staphylococcus aureus resistant to fifth-generation cephalosporins reveals potential non-meca mechanisms of resistance. PLoS ONE, 11. · DOI · Paper page
  95. Jones, 2002, In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci, J. Antimicrob. Chemother., 50, 915, 10.1093/jac/dkf249 · doi:10.1093/jac/dkf249
  96. Banerjee, 2008, In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 52, 2089, 10.1128/AAC.01403-07 · DOI
  97. Morroni, 2018, High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates from a Hospital in Central Italy, Antimicrob. Agents Chemother., 62, e01663-18, 10.1128/AAC.01663-18 · DOI · Paper page
  98. Salamaga, 2021, Demonstration of the role of cell wall homeostasis in Staphylococcus aureus growth and the action of bactericidal antibiotics, Proc. Natl. Acad. Sci. USA, 118, e2106022118, 10.1073/pnas.2106022118 · doi:10.1073/pnas.2106022118
  99. Roemer, 2013, Auxiliary factors: A chink in the armor of MRSA resistance to β-lactam antibiotics, Curr. Opin. Microbiol., 16, 538, 10.1016/j.mib.2013.06.012 · DOI
  100. Rohrer, 2002, Factors influencing methicillin resistance in staphylococci, Arch. Microbiol., 178, 165, 10.1007/s00203-002-0436-0 · DOI · Paper page
  101. Tomasz, 1994, Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 38, 2590, 10.1128/AAC.38.11.2590 · DOI · Paper page
  102. Kim, 2017, Antibiotic Resistance as a Stress Response: Recovery of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus “Auxiliary” (fem) Mutants by Induction of the Stringent Stress Response, Antimicrob. Agents Chemother., 61, e00313-17, 10.1128/AAC.00313-17 · doi:10.1128/aac.00313-17
  103. Dordel, 2014, Novel Determinants of Antibiotic Resistance: Identification of Mutated Loci in Highly Methicillin-Resistant Subpopulations of Methicillin-Resistant Staphylococcus aureus, MBio, 5, e01000-13, 10.1128/mBio.01000-13 · DOI
  104. Boonsiri, 2020, Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus, Sci. Rep., 10, 16907, 10.1038/s41598-020-73796-5 · DOI
  105. Gustafson, 1992, Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 36, 1367, 10.1128/AAC.36.7.1367 · DOI
  106. Wu, 1999, Antibiotic resistance as a stress response: Complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin, Microb. Drug Resist., 5, 163, 10.1089/mdr.1999.5.163 · DOI
  107. Baker, 2012, ClpXP, an ATP-powered unfolding and protein-degradation machine, Biochim. Biophys. Acta–Mol. Cell Res., 1823, 15, 10.1016/j.bbamcr.2011.06.007 · DOI · Paper page
  108. Jensen, C., Bæk, K.T., Gallay, C., Thalsø-Madsen, I., Xu, L., Jousselin, A., Ruiz Torrubia, F., Paulander, W., Pereira, A.R., and Veening, J.-W. (2019). The ClpX chaperone controls autolytic splitting of Staphylococcus aureus daughter cells, but is bypassed by β-lactam antibiotics or inhibitors of WTA biosynthesis. PLoS Pathog., 15. · DOI
  109. Baek, 2016, The cell wall polymer lipoteichoic acid becomes nonessential in Staphylococcus aureus cells lacking the ClpX chaperone, MBio, 7, e01228-16, 10.1128/mBio.01228-16 · DOI
  110. Frees, 2003, Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence, Mol. Microbiol., 48, 1565, 10.1046/j.1365-2958.2003.03524.x · DOI · Paper page
  111. Mogensen, 2014, β-lactam resistance in methicillin-resistant Staphylococcus aureus USA300 is increased by inactivation of the ClpXP protease, Antimicrob. Agents Chemother., 58, 4593, 10.1128/AAC.02802-14 · DOI
  112. Jelsbak, L., Ingmer, H., Valihrach, L., Cohn, M.T., Christiansen, M.H.G., Kallipolitis, B.H., and Frees, D. (2010). The Chaperone ClpX Stimulates Expression of Staphylococcus aureus Protein A by Rot Dependent and Independent Pathways. PLoS ONE, 5. · DOI
  113. Corrigan, R.M., Abbott, J.C., Burhenne, H., Kaever, V., and Gründling, A. (2011). c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress. PLoS Pathog., 7. · DOI · Paper page
  114. Corrigan, 2013, Cyclic di-AMP: Another second messenger enters the fray, Nat. Rev. Microbiol., 11, 513, 10.1038/nrmicro3069 · DOI · Paper page
  115. Griffiths, 2012, Loss of Function of the GdpP Protein Leads to Joint β-Lactam/Glycopeptide Tolerance in Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 579, 10.1128/AAC.05148-11 · DOI
  116. Roisin, 2018, Genetic Diversity among Staphylococcus aureus Isolates Showing Oxacillin and/or Cefoxitin Resistance Not Linked to the Presence of mec Genes, Antimicrob. Agents Chemother., 62, e00091-18, 10.1128/AAC.00091-18 · DOI · Paper page
  117. Banerjee, 2010, A mec A-Negative Strain of Methicillin-Resistant S taphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes, Antimicrob. Agents Chemother., 54, 4900, 10.1128/AAC.00594-10 · DOI · Paper page
  118. Maalej, 2012, Analysis of Borderline Oxacillin-Resistant Staphylococcus aureus (BORSA) Strains Isolated in Tunisia, J. Clin. Microbiol., 50, 3345, 10.1128/JCM.01354-12 · doi:10.1128/jcm.01354-12
  119. Poon, 2022, Loss of GdpP Function in Staphylococcus aureus Leads to β-Lactam Tolerance and Enhanced Evolution of β-Lactam Resistance, Antimicrob. Agents Chemother., 66, e01431-21, 10.1128/AAC.01431-21 · DOI
  120. Panchal, V.V., Griffiths, C., Mosaei, H., Bilyk, B., Sutton, J.A.F., Carnell, O.T., Hornby, D.P., Green, J., Hobbs, J.K., and Kelley, W.L. (2020). Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression. PLoS Pathog., 16. · DOI
  121. Aiba, 2013, Mutation of RNA Polymerase β-Subunit Gene Promotes Heterogeneous-to-Homogeneous Conversion of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 57, 4861, 10.1128/AAC.00720-13 · DOI
  122. Le, 2015, Quorum-sensing regulation in staphylococci—An overview, Front. Microbiol., 6, 1174, 10.3389/fmicb.2015.01174 · DOI · Paper page
  123. Duran, 1996, Impact of sar and agr on methicillin resistance in Staphylococcus aureus, FEMS Microbiol. Lett., 141, 255, 10.1111/j.1574-6968.1996.tb08394.x · DOI
  124. Song, 2020, Increased resistance of a methicillin-resistant Staphylococcus aureus Δagr mutant with modified control in fatty acid metabolism, AMB Express, 10, 64, 10.1186/s13568-020-01000-y · DOI
  125. Plata, 2011, Fate of Mutation Rate Depends on agr Locus Expression during Oxacillin-Mediated Heterogeneous-Homogeneous Selection in Methicillin-Resistant Staphylococcus aureus Clinical Strains, Antimicrob. Agents Chemother., 55, 3176, 10.1128/AAC.01119-09 · DOI
  126. Cheung, 2008, SarA of Staphylococcus aureus Binds to the sarA Promoter To Regulate Gene Expression, J. Bacteriol., 190, 2239, 10.1128/JB.01826-07 · DOI · Paper page
  127. Liu, 2006, Structural and function analyses of the global regulatory protein SarA from Staphylococcus aureus, Proc. Natl. Acad. Sci. USA, 103, 2392, 10.1073/pnas.0510439103 · DOI
  128. Cheung, 1992, Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr, Proc. Natl. Acad. Sci. USA, 89, 6462, 10.1073/pnas.89.14.6462 · DOI · Paper page
  129. Li, 2016, The Global Regulon sarA Regulates β-Lactam Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus In Vitro and in Endovascular Infections, J. Infect. Dis., 214, 1421, 10.1093/infdis/jiw386 · doi:10.1093/infdis/jiw386
  130. Kim, B., Lee, H.-J., Jo, S.-H., Kim, M.-G., Lee, Y., Lee, W., Kim, W., Joo, H.-S., Kim, Y.-G., and Kim, J.-S. (2022). Study of SarA by DNA Affinity Capture Assay (DACA) Employing Three Promoters of Key Virulence and Resistance Genes in Methicillin-Resistant Staphylococcus aureus. Antibiotics, 11. · DOI
  131. Wang, 2019, Hypericin enhances β-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant Staphylococcus aureus, Acta Pharm. Sin. B, 9, 1174, 10.1016/j.apsb.2019.05.002 · DOI
  132. Jarick, 2018, The serine/threonine kinase Stk and the phosphatase Stp regulate cell wall synthesis in Staphylococcus aureus, Sci. Rep., 8, 13693, 10.1038/s41598-018-32109-7 · doi:10.1038/s41598-018-32109-7
  133. Beltramini, 2009, Modulation of Cell Wall Structure and Antimicrobial Susceptibility by a Staphylococcus aureus Eukaryote-Like Serine/Threonine Kinase and Phosphatase, Infect. Immun., 77, 1406, 10.1128/IAI.01499-08 · DOI
  134. Tamber, 2010, Role of PknB Kinase in Antibiotic Resistance and Virulence in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strain USA300, Infect. Immun., 78, 3637, 10.1128/IAI.00296-10 · DOI
  135. Ohlsen, 2010, The impact of serine/threonine phosphorylation in Staphylococcus aureus, Int. J. Med. Microbiol., 300, 137, 10.1016/j.ijmm.2009.08.016 · DOI
  136. Dramsi, 2009, Characterization of a Serine/Threonine Kinase Involved in Virulence of Staphylococcus aureus, J. Bacteriol., 191, 4070, 10.1128/JB.01813-08 · DOI
  137. Sun, 2012, Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance, Proc. Natl. Acad. Sci. USA, 109, 15461, 10.1073/pnas.1205952109 · DOI · Paper page
  138. Chatterjee, 2020, Stp1 Loss of Function Promotes β-Lactam Resistance in Staphylococcus aureus That Is Independent of Classical Genes, Antimicrob. Agents Chemother., 64, e02222-19, 10.1128/AAC.02222-19 · doi:10.1128/aac.02222-19
  139. Lithgow, 2004, Role of the hprT–ftsH locus in Staphylococcus aureus, Microbiology, 150, 373, 10.1099/mic.0.26674-0 · DOI
  140. Yeo, W.-S., Jeong, B., Ullah, N., Shah, M., Ali, A., Kim, K., and Bae, T. (2021). FtsH Sensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics by Degrading YpfP, a Lipoteichoic Acid Synthesis Enzyme. Antibiotics, 10. · DOI
  141. Gustafson, 1994, The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon, J. Bacteriol., 176, 1460, 10.1128/jb.176.5.1460-1467.1994 · DOI
  142. Kondo, 2001, Eagle-Type Methicillin Resistance: New Phenotype of High Methicillin Resistance under mec Regulator Gene Control, Antimicrob. Agents Chemother., 45, 815, 10.1128/AAC.45.3.815-824.2001 · DOI
  143. Komatsuzawa, 2001, Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus, FEMS Microbiol. Lett., 203, 49, 10.1111/j.1574-6968.2001.tb10819.x · doi:10.1111/j.1574-6968.2001.tb10819.x
  144. Komatsuzawa, 2000, Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus, J. Antimicrob. Chemother., 45, 421, 10.1093/jac/45.4.421 · DOI
  145. Mikkelsen, 2021, The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids, Int. J. Antimicrob. Agents, 57, 106283, 10.1016/j.ijantimicag.2021.106283 · DOI
  146. Jousselin, 2016, The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A, Antimicrob. Agents Chemother., 60, 1656, 10.1128/AAC.02333-15 · DOI
  147. Roch, 2019, Thermosensitive PBP2a requires extracellular folding factors PrsA and HtrA1 for Staphylococcus aureus MRSA β-lactam resistance, Commun. Biol., 2, 417, 10.1038/s42003-019-0667-0 · DOI
  148. Jousselin, 2012, The Posttranslocational Chaperone Lipoprotein PrsA Is Involved in both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 3629, 10.1128/AAC.06264-11 · DOI
  149. Navratna, 2010, Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance, J. Bacteriol., 192, 134, 10.1128/JB.00822-09 · doi:10.1128/jb.00822-09
  150. Memmi, 2008, Staphylococcus aureus PBP4 Is Essential for β-Lactam Resistance in Community-Acquired Methicillin-Resistant Strains, Antimicrob. Agents Chemother., 52, 3955, 10.1128/AAC.00049-08 · DOI · Paper page
  151. Chatterjee, 2017, PBP4 Mediates β-Lactam Resistance by Altered Function, Antimicrob. Agents Chemother., 61, e00932-17, 10.1128/AAC.00932-17 · DOI
  152. Silber, 2020, Cell division protein FtsZ: From structure and mechanism to antibiotic target, Future Microbiol., 15, 801, 10.2217/fmb-2019-0348 · DOI
  153. Lee, 2011, Antagonism of Chemical Genetic Interaction Networks Resensitize MRSA to β-Lactam Antibiotics, Chem. Biol., 18, 1379, 10.1016/j.chembiol.2011.08.015 · DOI
  154. Huh, 2021, Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus, J. Bacteriol., 203, 204
  155. Neuhaus, 2003, A Continuum of Anionic Charge: Structures and Functions of D-Alanyl Teichoic Acids in Gram-Positive Bacteria, Microbiol. Mol. Biol. Rev., 67, 686, 10.1128/MMBR.67.4.686-723.2003 · DOI · Paper page
  156. Coupri, 2021, Inhibition of D-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus, J. Antimicrob. Chemother., 76, 2778, 10.1093/jac/dkab287 · doi:10.1093/jac/dkab287

Cited by

See all 171

Metadata

Authors
Lade, H., & Kim, J.-S.
Venue
Antibiotics
Publisher
MDPI AG
Published
2023-08-24
Volume
12
Issue
9
Pages
1362
ISSN
2079-6382
Cited by
171
References
5
Language
en
Funders
  • Korean government, Ministry of Science and ICT (MSIT) (2017M3A9E4077232)
  • Kangdong Sacred Heart Hospital Research Fund (2017M3A9E4077232)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review. https://app.cochat.ai/papers/10.3390/antibiotics12091362
The paper
Lade, H., & Kim, J.-S. (2023). Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review. Antibiotics. https://doi.org/10.3390/antibiotics12091362

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.